Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1998 | 06-1998 | 03-1998 | 12-1997 | 09-1997 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 2,290 | 2,360 | 2,200 | 3,018 | 1,800 |
| TOTAL | $2,290 | $2,360 | $2,200 | $3,018 | $1,800 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 20,376 | N/A |
| Investments And Advances | 2,910 | 4,490 | 6,450 | 6,351 | 6,140 |
| Other Non-Current Assets | 16,240 | 16,360 | 17,350 | 18,160 | 16,620 |
| TOTAL | $19,150 | $20,850 | $23,800 | $44,887 | $22,760 |
| Total Assets | $21,440 | $23,210 | $26,000 | $47,905 | $24,560 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 30 | 0 | 0 | 0 | N/A |
| Accounts payable and accrued liabilities | 15,620 | 15,600 | 16,620 | 5,957 | 0 |
| Accrued Expenses | 0 | 0 | 0 | 13,335 | N/A |
| Other current liabilities | 13,340 | 13,850 | 13,810 | 15,557 | 13,300 |
| TOTAL | $28,990 | $29,450 | $30,430 | $34,849 | $13,300 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,570 | 3,450 | 3,430 | 3,606 | 610 |
| TOTAL | $5,610 | $5,160 | $5,300 | $4,796 | $610 |
| Total Liabilities | $34,600 | $34,610 | $35,730 | $39,645 | $13,910 |
| Shareholders' Equity | |||||
| Common Shares | 10 | 10 | 10 | 14 | 10 |
| Other shareholders' equity | 100 | 470 | 420 | 240 | -300 |
| TOTAL | $74,120 | $73,680 | $73,340 | $73,876 | $65,890 |
| Total Liabilities And Equity | $108,720 | $108,290 | $109,070 | $113,521 | $79,800 |